Area of research
Pharmacology · Molecular Medicine
Research interest
Research interests include Medicine, Internal medicine, Pemetrexed, Oncology, Adverse effect, and Pertuzumab.
Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial
418P Two-year follow-up data on the efficacy and safety of KN026, a HER2-targeted bispecific antibody combined with docetaxel as first-line treatment for HER2-positive recurrent/metastatic breast cancer